This study will evaluate a blood sugar lowering insulin, LY900014, delivered by an insulin pump continuously under the skin. The study will be conducted in participants with type 1 diabetes mellitus to investigate how the human body processes LY900014 and its effect on blood sugar levels when it is delivered via an insulin pump. Side effects and tolerability will be documented.